Bal Pharma Limited (BALPHARMA) — Net Asset Quality Index
Bal Pharma Limited (BALPHARMA) has a Net Asset Quality Index of 21.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs3.76 Billion minus total liabilities of Rs2.93 Billion yields net assets of Rs822.52 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of Bal Pharma Limited for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Bal Pharma Limited Net Asset Quality Index Over Time (2006–2026)
This chart shows how Bal Pharma Limited's Net Asset Quality Index has evolved across 21 annual periods from 2006 to 2026. As of March 2026, the index stands at 21.9%, representing net assets of Rs822.52 Million against total assets of Rs3.76 Billion INR. For live market cap and overall valuation, see BALPHARMA stock market capitalisation.
Annual Net Asset Quality Index for Bal Pharma Limited (2006–2026)
The table below presents the year-by-year Net Asset Quality Index for Bal Pharma Limited from 2006 to 2026, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check BALPHARMA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 21.9% | Rs822.52 Million | Rs3.76 Billion | Rs2.93 Billion | ▼ -1.2 pp |
| 2025 | 23.1% | Rs774.04 Million | Rs3.36 Billion | Rs2.58 Billion | ▲ +1.4 pp |
| 2024 | 21.7% | Rs692.61 Million | Rs3.20 Billion | Rs2.50 Billion | ▲ +1.3 pp |
| 2023 | 20.3% | Rs637.02 Million | Rs3.13 Billion | Rs2.49 Billion | ▼ -2.1 pp |
| 2022 | 22.5% | Rs584.92 Million | Rs2.61 Billion | Rs2.02 Billion | ▲ +0.2 pp |
| 2021 | 22.2% | Rs533.54 Million | Rs2.40 Billion | Rs1.87 Billion | ▲ +3.2 pp |
| 2020 | 19.0% | Rs453.38 Million | Rs2.38 Billion | Rs1.93 Billion | ▼ -4.0 pp |
| 2019 | 23.0% | Rs602.21 Million | Rs2.61 Billion | Rs2.01 Billion | ▼ -0.9 pp |
| 2018 | 23.9% | Rs602.01 Million | Rs2.52 Billion | Rs1.92 Billion | ▼ -2.2 pp |
| 2017 | 26.1% | Rs600.31 Million | Rs2.30 Billion | Rs1.70 Billion | ▲ +0.1 pp |
| 2016 | 25.9% | Rs547.22 Million | Rs2.11 Billion | Rs1.56 Billion | ▼ -7.7 pp |
| 2015 | 33.7% | Rs551.68 Million | Rs1.64 Billion | Rs1.09 Billion | ▲ +1.3 pp |
| 2014 | 32.3% | Rs500.50 Million | Rs1.55 Billion | Rs1.05 Billion | ▲ +2.6 pp |
| 2013 | 29.8% | Rs446.18 Million | Rs1.50 Billion | Rs1.05 Billion | ▲ +1.4 pp |
| 2012 | 28.4% | Rs400.56 Million | Rs1.41 Billion | Rs1.01 Billion | ▲ +1.6 pp |
| 2011 | 26.7% | Rs361.75 Million | Rs1.35 Billion | Rs991.28 Million | ▼ -2.1 pp |
| 2010 | 28.8% | Rs357.62 Million | Rs1.24 Billion | Rs884.40 Million | ▼ -1.8 pp |
| 2009 | 30.6% | Rs372.35 Million | Rs1.22 Billion | Rs843.01 Million | ▼ -1.6 pp |
| 2008 | 32.2% | Rs350.32 Million | Rs1.09 Billion | Rs738.08 Million | ▼ -4.7 pp |
| 2007 | 36.9% | Rs334.02 Million | Rs905.28 Million | Rs571.26 Million | ▲ +0.2 pp |
| 2006 | 36.7% | Rs323.02 Million | Rs881.03 Million | Rs558.01 Million | — |